JPRN-UMIN000038620
Completed
未知
A study of the contributions of neurotransmitter systems and abnormal protein pathologies in the brain to the symptoms of FTLD-ALS spectrum patients - A study of the contributions of neurotransmitter systems and abnormal protein pathologies in the brain to the symptoms of FTLD-ALS spectrum patients
ational Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology0 sites50 target enrollmentDecember 1, 2019
ConditionsFTLD-ALS spectrum
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- FTLD-ALS spectrum
- Sponsor
- ational Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)FTLD\-ALS spectrum patients 1\.Subjects with organic brain complications/disorders 2\.Subjects with substance\-related disorders 3\.Subjects with severe physical complications/disorders or a history of such conditions 4\.Subjects with claustrophobia 5\.Pregnant, possibly pregnant or lactating women 6\.From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study (at National Institutes for Quantum and Radiological Science and Technology) 7\.Subjects with metallic medical device in the body (at Nagoya university) 8\.Subjects with tattoo (at Nagoya university) 9\.Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study 2\)Healthy volunteers 1\.Subjects with organic brain complications/disorders 2\.Subjects with substance\-related disorders 3\.Subjects with severe physical complications/disorders or a history of such conditions 4\.Subjects with metallic medical device in the body 5\.Subjects with tattoo 6\.Subjects with claustrophobia 7\.Pregnant, possibly pregnant or lactating women 8\.From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 6 months prior to the start of this study (at National Institutes for Quantum and Radiological Science and Technology) 9\.Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Potential roles of neurotransmitter receptors and mitochondria in the pathophysiology of autism spectrum disorder: A PET studyAutism spectrum disorderJPRN-UMIN000029183Hamamatsu University school of medicine47
Active, not recruiting
Not Applicable
Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffering from schizophrenia treated with quetiapine (Seroquel®). - Quetiapine-StudyPatients have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV.EUCTR2006-002342-11-DEKlinikum Fulda gAG22
Completed
Not Applicable
The role of catecholaminergic neurotransmission in attention and cognitioaandacht en leer problemen10037173NL-OMON43560Medisch Universitair Ziekenhuis Maastricht20
Not yet recruiting
Not Applicable
Effect of brain and spinal cord stimulation on limb recovery in complete spinal cord injury patientsHealth Condition 1: S341- Other and unspecified injury of lumbar and sacral spinal cordCTRI/2022/11/047038Department of Biotechnology
Completed
Not Applicable
Investigating neurotransmitters by high-sensitivity proton MRSbrain diseasesJPRN-UMIN000022286ational Institutes for Quantum and Radiological Science and Technology24